163 related articles for article (PubMed ID: 6299046)
1. [Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension].
Stanek B; Templ H; Pohanka E; Silberbauer K
Acta Med Austriaca; 1982; 9(5-6):175-80. PubMed ID: 6299046
[No Abstract] [Full Text] [Related]
2. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
Stanek B; Silberbauer K
Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
[No Abstract] [Full Text] [Related]
4. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of essential arterial hypertension of moderate severity with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
Guerrera G; Melina D
Minerva Cardioangiol; 1983 Mar; 31(3):101-6. PubMed ID: 6304570
[No Abstract] [Full Text] [Related]
6. Urinary 6-keto-PGF1 alpha after captopril and indomethacin: possible contribution of PGI2 to the antihypertensive mechanism of ACE inhibitors.
Minuz P; Degan M; Covi G; Lechi C; Velo GP; Lechi A
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():199-202. PubMed ID: 2988309
[No Abstract] [Full Text] [Related]
7. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
Santucci A; Aguglia F; Ficara C
Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
[No Abstract] [Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors.
Dipalma JR
Am Fam Physician; 1980 Nov; 22(5):164-5. PubMed ID: 6158857
[No Abstract] [Full Text] [Related]
9. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
[No Abstract] [Full Text] [Related]
10. [Effect of captopril in essential hypertension (author's transl)].
Mimran A; Targhetta R; Laroche B
Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
[TBL] [Abstract][Full Text] [Related]
11. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
Fagard R; Amery A; Lijnen P; Staessen J
Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761
[TBL] [Abstract][Full Text] [Related]
12. Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.
MacGregor GA; Markandu ND; Roulston JE; Jones JC
Br Med J; 1979 Nov; 2(6198):1106-9. PubMed ID: 229941
[TBL] [Abstract][Full Text] [Related]
13. [Changes in angiotensinogen and des-angiotensin I-angiotensinogen in man and rat upon inhibition of converting enzyme].
Clauser E; Genain C; Bouhnik J; Corvol P; Ménard J
Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():157-61. PubMed ID: 6287956
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of the angiotensin I converting enzyme with SQ-14225 (captopril) in the medical treatment of severe renovascular hypertension].
Martínez Amenós A; Caralps A; Rama H; Sarrias X; Alsina J
Rev Clin Esp; 1981 Sep; 162(6):265-8. PubMed ID: 7036249
[No Abstract] [Full Text] [Related]
15. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of refractory arterial hypertension with a converting enzyme inhibiting drug (Captopril)].
Lavezzaro GC; Angelino PF; Gastaldo D; Minelli M; Paccotti P; Angeli A
Minerva Cardioangiol; 1981 Oct; 29(10):519-25. PubMed ID: 7033830
[No Abstract] [Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
Waeber B; Brunner HR; Wauters JP; Gavras H
Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
[No Abstract] [Full Text] [Related]
18. Inhibition of angiotensin-converting enzyme: therapeutic implications.
Rotmensch HH; Vlasses PH; Ferguson RK
Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
[No Abstract] [Full Text] [Related]
19. [Use of SQ 14225 in the treatment of essential arterial hypertension].
Degli Esposti E; Chiarini C; Fusaroli M; Masi A; Santoro A; Sturani A; Zuccalà A; Zucchelli P
Clin Ter; 1981 Apr; 97(2):153-63. PubMed ID: 6263540
[No Abstract] [Full Text] [Related]
20. [Pharmacological effects of captopril].
Rubin B; Antonaccio J
Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
